JD.Com Inc vs Philip Morris International Inc. — how do they compare? JD.Com Inc trades at $30.82 (market cap $41.80B), while Philip Morris International Inc. trades at $192.33 (market cap $300.37B). The key difference: Philip Morris International Inc. is far larger — about 7.2× JD.Com Inc's market cap, and JD.Com Inc pays the higher dividend (3.27%). Which is the better fit depends on your goals.
| JD | PM | |
|---|---|---|
Market Cap | $41.80B | $300.37B |
Sector | Consumer Cyclical | Consumer Staples |
52-Week High | $36.17 | $192.98 |
52-Week Low | $25.19 | $144.33 |
Enterprise Value | $27.96B | $346.86B |
Dividend Yield | 3.27% | 3.05% |
Signals from Pluang's Aura AI — not financial advice
JD.com trades at $30.60, up 3.31% with strong recent earnings beats. The stock shows bullish technical signals with moving averages supporting upside, while RSI levels indicate potential overbought conditions. Fundamentally, revenue grew to $1.31 trillion in 2025, though net income margin compressed to 1.05%. Analyst consensus remains strongly bullish with a $39.50 price target, representing significant upside potential from current levels.
JD offers attractive valuation with P/S of 0.22 and P/E of 21.75, but faces risks from Chinese regulatory environment and ongoing margin pressure. The company maintains robust cash flow generation and shareholder returns through buybacks. Near-term catalyst includes Q2 2026 earnings release with expected EPS of $0.86.
No Aura AI signal available yet.
Trailing returns across standard periods
JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
Read more on JD →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →